ChartRow logo
Share this page
DFTX
$32.10-6.30%
as of close, Oct 16, 2026
☾ AH $32.10 -6.30%
Definium Therapeutics Inc.Stock · HealthcareRussell 2000 0.2%Nasdaq Composite 0.009%Russell 3000 0.008%
PeersMRNALLYMDTUNHJNJTMO

Definium Therapeutics Inc. total returns by year (including dividends)

As of market close, Oct 16, 2026

Definium Therapeutics Inc. total returns by year (2017–2026)#

Definium Therapeutics Inc. annual returns by year
YearTotal return
2026YTD
+139.7%
2025
+92.4%
2024
+90.2%
2023
+66.4%
2022
-89.4%
2021
-54.8%
2020
+5346.4%
2019
+27.3%
2018
-85.2%
2017
-45.9%
Annualized
+20.2%
2017–2026
Average year
+594.2%
9 full years
Best year
+5346.4%
2020
Worst year
-89.4%
2022
Positive years
5/9
56% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on DFTX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Definium Therapeutics Inc.'s average annual return?
Since 2017, Definium Therapeutics Inc. (DFTX) has returned about 20.2% a year (the compound annual growth rate) and an average calendar-year return of 594.2%.
What were Definium Therapeutics Inc.'s best and worst years?
Over 2017–2026, the best year was 2020 (+5346.4%) and the worst was 2022 (-89.4%).
How often is Definium Therapeutics Inc. up in a year?
5 of the 9 full years since 2017 were positive — about 56% of the time.

More on Definium Therapeutics Inc.